Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fertyon-F is a multi-ingredient dietary supplement developed by Liveon Healthcare, specifically formulated to address female infertility and Polycystic Ovary Syndrome (PCOS). The product typically contains a combination of Myo-inositol and D-chiro-inositol in a physiologically relevant 40:1 ratio, alongside Vitamin D3 and Folic acid. Its mechanism of action is centered on improving insulin sensitivity and restoring hormonal balance, which are often disrupted in women with PCOS. Myo-inositol and D-chiro-inositol act as second messengers in the insulin signaling pathway, helping to reduce insulin resistance and hyperandrogenism, thereby improving oocyte quality and menstrual regularity. Vitamin D3 and Folic acid further support reproductive health by enhancing follicular development and providing essential nutrients for early fetal growth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fertyon-F.